Literature DB >> 16369495

Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells.

S Tang1, M Tao, J P McCoy, Z M Zheng.   

Abstract

RNA interference-mediated gene silencing has the potential to block gene expression. A synthetic double-stranded small interfering RNA (siRNA) based on a sequence motif of 21 nucleotides from human papillomavirus 16 (HPV16) E6E7 bicistronic RNA was found to be a potent siRNA that suppresses expression of both the E6 and E7 oncogenes in HPV16+ CaSki and SiHa cells. When stably expressed as a short hairpin RNA in these cells, however, siRNA silencing of E6 and E7 expression was efficient only at early cell passages, but became inefficient with increased cell passages despite the continued expression of the siRNA at the same level. The loss of the siRNA function was duplicable in stable p53 siRNA cells, but not in stable lamin A/C siRNA cells, suggesting that it is gene selective. The cells resistant to siRNA function retained normal siRNA processing, duplex unwinding and degradation of the unwound sense strand and RNA-induced silencing complex formation, suggesting that loss of the siRNA function occurred at a later step. Surprisingly, the siRNA-resistant cells were found to express notably a cytoplasmic protein of approximately 50 kDa that specifically and characteristically interacted with the unwound, antisense strand E7 siRNA. Altogether, our data indicate that a potent siRNA targeting to an essential or regulatory gene might induce a cell to develop siRNA-suppressive function.

Entities:  

Mesh:

Year:  2006        PMID: 16369495      PMCID: PMC1800826          DOI: 10.1038/sj.onc.1209244

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

1.  RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells.

Authors:  Allison H S Hall; Kenneth A Alexander
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  A viral suppressor of RNA silencing differentially regulates the accumulation of short interfering RNAs and micro-RNAs in tobacco.

Authors:  Allison C Mallory; Brenda J Reinhart; David Bartel; Vicki B Vance; Lewis H Bowman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-25       Impact factor: 11.205

3.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

Review 4.  Killing the messenger: short RNAs that silence gene expression.

Authors:  Derek M Dykxhoorn; Carl D Novina; Phillip A Sharp
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

5.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.

Authors:  Yan Zeng; Rui Yi; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

6.  Induction of an interferon response by RNAi vectors in mammalian cells.

Authors:  Alan J Bridge; Stephanie Pebernard; Annick Ducraux; Anne-Laure Nicoulaz; Richard Iggo
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

7.  P1/HC-Pro, a viral suppressor of RNA silencing, interferes with Arabidopsis development and miRNA unction.

Authors:  Kristin D Kasschau; Zhixin Xie; Edwards Allen; Cesar Llave; Elisabeth J Chapman; Kate A Krizan; James C Carrington
Journal:  Dev Cell       Date:  2003-02       Impact factor: 12.270

8.  In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA.

Authors:  Mitsuo Yoshinouchi; Taketo Yamada; Masahiro Kizaki; Jin Fen; Takeyoshi Koseki; Yasuo Ikeda; Tatsuji Nishihara; Kenji Yamato
Journal:  Mol Ther       Date:  2003-11       Impact factor: 11.454

9.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

10.  siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells.

Authors:  Karin Butz; Tutik Ristriani; Arnd Hengstermann; Claudia Denk; Martin Scheffner; Felix Hoppe-Seyler
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

View more
  21 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

Review 2.  Regulation of cellular miRNA expression by human papillomaviruses.

Authors:  Zhi-Ming Zheng; Xiaohong Wang
Journal:  Biochim Biophys Acta       Date:  2011-05-17

3.  Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.

Authors:  Xiaohong Wang; Craig Meyers; Ming Guo; Zhi-Ming Zheng
Journal:  Int J Cancer       Date:  2011-02-26       Impact factor: 7.396

Review 4.  siRNA-based topical microbicides targeting sexually transmitted infections.

Authors:  Joseph A Katakowski; Deborah Palliser
Journal:  Curr Opin Mol Ther       Date:  2010-04

5.  Identification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells.

Authors:  Francoise A Gourronc; William M Rockey; William H Thiel; Paloma H Giangrande; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-09-08       Impact factor: 3.616

6.  An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor.

Authors:  Shuang Tang; Andrea S Bertke; Amita Patel; Kening Wang; Jeffrey I Cohen; Philip R Krause
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

7.  Control of the papillomavirus early-to-late switch by differentially expressed SRp20.

Authors:  Rong Jia; Xuefeng Liu; Mingfang Tao; Michael Kruhlak; Ming Guo; Craig Meyers; Carl C Baker; Zhi-Ming Zheng
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

8.  Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs.

Authors:  Shuang Tang; Amita Patel; Philip R Krause
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

9.  Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6.

Authors:  Xiaohong Wang; Hsu-Kun Wang; J Philip McCoy; Nilam S Banerjee; Janet S Rader; Thomas R Broker; Craig Meyers; Louise T Chow; Zhi-Ming Zheng
Journal:  RNA       Date:  2009-03-03       Impact factor: 4.942

10.  Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene.

Authors:  J E Hanning; H K Saini; M J Murray; S van Dongen; M P A Davis; E M Barker; D M Ward; C G Scarpini; A J Enright; M R Pett; N Coleman
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.